Financhill
Sell
27

NIPG Quote, Financials, Valuation and Earnings

Last price:
$1.52
Seasonality move :
--
Day range:
$1.31 - $1.40
52-week range:
$0.99 - $17.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.88x
P/B ratio:
0.32x
Volume:
172.5K
Avg. volume:
102.5K
1-year change:
--
Market cap:
$75.4M
Revenue:
$85.3M
EPS (TTM):
-$2.09

NIPG Analysts' Consensus Rating

No consensus rating exists at this time due to lack of analyst coverage.

Consensus Price Target

$6.00

Highest Price Target

$6.00

Lowest Price Target

$6.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 0 0

Hold 0 0 0

Sell 0 0 0
Consensus -- -- --

NIPG Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is IONQ The Next NVIDIA?
Is IONQ The Next NVIDIA?

Quantum computing startup IonQ (NYSE:IONQ) has seen its stock skyrocket…

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 47x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
81
LYRA alert for Jun 3

Lyra Therapeutics [LYRA] is up 60.25% over the past day.

Buy
84
VERA alert for Jun 3

Vera Therapeutics [VERA] is down 1.95% over the past day.

Buy
80
KYMR alert for Jun 3

Kymera Therapeutics [KYMR] is up 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock